1. Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. (4th January 2022) Authors: Christine, Chadwick W.; Richardson, R. Mark; Van Laar, Amber D.; Thompson, Marin E.; Fine, Elisabeth M.; Khwaja, Omar S.; Li, Chunming; Liang, Grace S.; Meier, Andreas; Roberts, Eiry W.; Pfau, Madeline L.; Rodman, Josh R.; Bankiewicz, Krystof S.; Larson, Paul S. Journal: Neurology Issue: Volume 98:Number 1(2022) Page Start: e40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial. (4th January 2022) Authors: Christine, Chadwick W.; Richardson, R. Mark; Van Laar, Amber D.; Thompson, Marin E.; Fine, Elisabeth M.; Khwaja, Omar S.; Li, Chunming; Liang, Grace S.; Meier, Andreas; Roberts, Eiry W.; Pfau, Madeline L.; Rodman, Josh R.; Bankiewicz, Krystof S.; Larson, Paul S. Journal: Neurology Issue: Volume 98:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗